Hypera S.A. (OTCMKTS:HYPMY – Get Rating) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $7.58 and traded as high as $8.14. Hypera shares last traded at $8.12, with a volume of 2,876 shares traded.

Hypera Price Performance

The company has a market cap of $5.23 billion, a PE ratio of 19.33 and a beta of 0.82. The company has a fifty day moving average price of $7.58 and a 200 day moving average price of $7.25.

About Hypera

(Get Rating)

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.

Featured Articles

• Get a free copy of the StockNews.com research report on Hypera (HYPMY)
• MarketBeat: Week in Review 8/1 – 8/5
• How to Use High Beta Stocks to Maximize Your Investing Profits
• Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
• Why Apple Could Be At All-Time Highs By Year End
• Beyond Meat Is Not Beyond Hope, And It's Cheap

Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.